HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc
HDBuzz interviews three top scientists from CHDI, the biggest funder and driver of HD research worldwide
Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies
Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD
Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene
Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co
New data suggest there may be twice as many people with HD symptoms as previously thought – and even more at risk
Merger of two major Huntington’s Disease observational trials creates ENROLL-HD
Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex